Cargando…
Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that is best treated in a multidisciplinary fashion using surgery, chemotherapy, and radiation. Adjuvant chemotherapy has shown to have a significant survival benefit in patients with resected PDAC. However, up to 50% of patients fa...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316910/ https://www.ncbi.nlm.nih.gov/pubmed/34366611 http://dx.doi.org/10.3748/wjg.v27.i27.4383 |